ANNOVIS BIO (ANVS)
US03615A1088 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 1,785.47% | N/A -54.39% | N/A 236.90% | N/A 90.63% | N/A 70.50% | ||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A 45.39% | N/A -79.12% | N/A -43.50% | N/A -15.63% | N/A -128.65% | N/A 110.64% | N/A 925.54% | N/A 104.45% | |
| EBIT YoY % growth | -680K | -710K -4.41% | -1.61M -126.76% | -6.64M -312.42% | -14.54M -118.98% | -25.51M -75.45% | -45.035M -76.54% | N/A 41.65% | N/A -46.91% | N/A -38.95% | N/A -58.61% | N/A 27.33% | N/A 219.98% | N/A 265.39% | N/A 99.05% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -1.90 -238.68% | -3.10 -63.16% | -6.13 -97.74% | N/A 69.97% | N/A -1.30% | N/A 22.34% | N/A 60.56% | N/A 119.64% | N/A 509.09% | N/A 346.27% | N/A 149.83% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 83.95% | -0.33 -227.08% | -0.45 -39.83% | -0.50 48.54% | -0.58 -62.69% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -4.998M 55.45% | -6.528M | -12.648M -217.95% | -13.158M -53.57% | -13.158M -163.27% |
| EBIT Q2Q % growth | -5.336M 48.90% | -6.027M 22.83% | -9.901M -27.54% | -11.037M -151.55% | -11.919M -123.36% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.97 40.49% | -0.54 | -0.43 | -80.79% |
| Q2 2024 Q2Q % growth | -0.32 70.09% | -0.64 | 0.32 | 50.15% |
| Q1 2024 Q2Q % growth | -0.10 91.60% | -0.81 | 0.71 | 87.72% |
| Q4 2023 Q2Q % growth | -2.24 -489.47% | -1.33 | -0.91 | -68.35% |
| Q3 2023 Q2Q % growth | -1.63 -75.27% | -1.11 | -0.52 | -46.56% |
| Q2 2023 Q2Q % growth | -1.07 | -1.16 | 0.09 | 8.12% |
| Q1 2023 Q2Q % growth | -1.19 -65.28% | -0.34 | -0.85 | -249.30% |
| Q4 2022 Q2Q % growth | -0.38 49.33% | -1.07 | 0.69 | 64.61% |
| Q3 2022 Q2Q % growth | -0.93 -165.71% | -1.03 | 0.10 | 10.02% |
| Q2 2022 Q2Q % growth | -1.07 -214.71% | -0.66 | -0.41 | -62.64% |
| Q1 2022 Q2Q % growth | -0.72 -56.52% | -0.59 | -0.13 | -21.70% |
| Q4 2021 Q2Q % growth | -0.75 -359.56% | -0.26 | -0.50 | -194.12% |
| Q3 2021 Q2Q % growth | -0.35 -133.33% | -0.45 | 0.10 | 22.01% |
| Q2 2021 Q2Q % growth | -0.34 | -0.38 | 0.04 | 9.91% |
| Q3 2020 Q2Q % growth | -0.15 | -0.15 | 0.00 | 1.96% |
| Q2 2020 Q2Q % growth | -0.34 | -0.15 | -0.19 | -122.22% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -10.7% | -10.7% | -21.96% | -21.96% |
| Revenue | N/A | N/A | N/A | N/A |